Molecular Partners Publishes Invitation to Extraordinary General Meeting to be held on October 31, 2017
(WorldNews Switzerland)

Zurich-Schlieren, October 3, 2017. Molecular Partners AG (SIX: MOLN), a clinical-stage biopharmaceutical company that is developing a new class of drugs, known as DARPin® therapies, today published the Invitation to the Extraordinary General Meeting which will be held on Tuesday, October 31, 2017, 2.00 pm CET (doors open at 1.00 pm), at the registered office of the company, 5 floor, Wagistrasse 14, 8952 Schlieren, Switzerland. At this Extraordinary General Meeting William (Bill) Burns and Patrick Amstutz will be proposed for election to the Board of Directors. Link to the Invitation to the Extraordinary General Meeting with the corresponding agenda items. Link zur Einladung zur...